Wise Group plc
WSEWise Group plc's earnings have outrun its stock. EPS grew −8.0% in a year against a −9.9% price move.
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.
The price is topping out (1 weeks in). Underneath, the last four quarters read improving — profit −13.3% year on year, and 867% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Wise Group plc trades at $12.4, losing momentum at the top and 1 weeks into that stage. That is +0.0% against its own 200-day average. It sits at 31% of a 52-week range of $11 to $16. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (10 weeks and counting).
Today the stock is losing momentum at the top — week 1 of stage 3. At $12.4 it trades +0.0% versus its 200-day average and sits at 31% of its 52-week range ($11–$16).
Against the market, two honest reads. Cumulative: over the last 5.1 years the stock moved −6% while the S&P 500 moved +77% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (10 weeks and counting; last ahead the week of 2026-05-29) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
Wise Group plc trades at 25.0× P/E, against too little history to rank. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 25.0× is against too little history to rank. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved −8.0% against a −9.9% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 3y, of the +8.2%/yr price move, ~+54.9%/yr came from earnings growth and ~−46.7 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Wise Group plc reads as mixed on its fundamental arc. Mixed — growth is normalizing off a hyper-growth base: revenue growth has eased from +73.1% at its peak to +48.7% but is still expanding, ROCE holding at 45.0%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +19.0% | +28.1% | — | — |
| Profit | −9.1% | +52.9% | — | — |
| EPS | −8.0% | +51.2% | — | — |
| Stock price | −9.9% | +8.2% | −2.1% | — |
4-Factor Sector Score
43.6/100 — rank 26 of 27 in Information Technology Services · 49% evidence confidence · provisional, ranked below fully-evidenced peers
Wise Group plc scores 43.6 out of 100 against the 27 companies it is compared with in Information Technology Services, ranking 26. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 16.2 + 11.7 + 9.2 + 6.5 = 43.6. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Wise Group plc reported $0.6 B of revenue in the Sep 25 quarter, +9.3% year on year. That is the 12th straight quarter of year-on-year growth. Over 4 years it has compounded at 36.0% a year. The last full year, FY26, came in at $2.5 B. The last four reported quarters add to $2.3 B.
FY26 revenue came in at $2.5 B (+19.0% on the year), capping 4 years at 36.0% compound. The latest quarter (Sep 25) printed $0.6 B, +9.3% year on year — the 12th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +22.1% growth against the decade's 36.0% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +48.7% over the last 4 quarters against +64.0%/yr over the last 8 — rolling over; TTM profit +100.0% vs +205.5%/yr — rolling over.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Wise Group plc's operating margin is 30.5% in the Sep 25 quarter, −6.5 percentage points against the same quarter a year ago. Across the last four quarters the operating margin has moved +0.5 percentage points. Across 5 fiscal years the operating margin has ranged 8.2% to 36.5%. The current quarter sits inside that band.
The latest quarter's operating margin is 30.5%, −6.5 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 8.2%–36.5%.
Why the margin moved: operating margin went +0.5 pp year on year while gross margin went +4.7 pp — the gain came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Wise Group plc earned $0.1 B of net profit in the Sep 25 quarter, −13.3% year on year. Full-year FY26 profit was $0.5 B. The 4-year compound rate is 88.0%. That is 22.0% of the quarter's revenue. The same quarter a year earlier earned $0.1 B.
Sep 25 profit was $0.1 B, −13.3% year on year. On the full year, FY26 printed $0.5 B (−9.1%), and the 4-year compound rate is 88.0%.
🚨 Why profit moved: revenue contributed +9.3% and the margin −6.5 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit +26.7% vs revenue +22.1%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 867% of Wise Group plc's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was $5.7 B of operating cash against $0.5 B of profit. After $0.0 B of capital spending, $7.5 B was left as free cash.
FY26: operating cash of $5.7 B against reported profit of $0.5 B, leaving free cash of $7.5 B after $0.0 B of capital spending. Across the last 3 fiscal years the conversion rate is 867% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Wise Group plc does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY26 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $0.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Wise Group plc earns a ROE of 26% in FY26. That is up from a trough of 7% in FY22. Return on invested capital clears the cost of that capital by +25.0 percentage points, so growth here adds value rather than only size. The wiring behind it is 20.0% net margin on 0.08× asset turns.
FY26 ROE is 26%, recovered from a FY22 trough of 7% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 20.0% net margin × 0.08× asset turns × 17.23× balance-sheet leverage ≈ 27.6% on equity. Margin is doing the heavy lifting; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 31.9% − 6.9% = a +25.0 pp spread. The 6.9% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. A spread this wide means every dollar reinvested creates more than a dollar of value — the engine compounds.
Dividend
Wise Group plc pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.
Wise Group plc does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Wise Group plc carries total debt of $0.5 B against shareholder equity of $1.9 B as of Mar 26, a debt-to-equity of 0.25 — effectively unlevered. On the annual view that ratio went from 0.24 in FY22 to 0.25 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of $0.5 B against shareholder equity of $1.9 B — a debt-to-equity of 0.25. On the annual view, debt-to-equity went from 0.24 (FY22) to 0.25 (FY26). The returns on this page are earned, not borrowed.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
0.5% of Wise Group plc's tradable float is currently sold short — the crowd is not positioned against this stock. At typical trading volumes those positions would take about 2.6 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 0.5% of the float is sold short, and at typical trading volumes it would take about 2.6 days to buy those positions back. The crowd is not positioned against this stock. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Wise Group plc: the Z-score reads 0.60. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits inside the distress zone. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
🚨 Why it matters: a Z-score of 0.60 is inside the distress zone — the balance sheet is a real risk, not a detail.
The safety line in one sentence: the Z-score reads 0.60.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Science Applications International CorporationSAIC | 67.6/100Favorable setup85% evidence | BREAKING OUT | 21.5/35 Revenue -2.9% · PAT 14.7% · OPM change 3 pp 95% evidence | 12.6/25 ROCE 4.5% · OPM 9.4% 76% evidence | 15.7/20 P/E 10.8× · PEG 0.44 65% evidence | 17.8/20 RS sector 8.2% · RS bench 6% · 1Y 3.2%7 of 12 weeks ahead 100% evidence |
| Exact sum: 21.5 + 12.6 + 15.7 + 17.8 = 67.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Jack Henry & Associates, Inc.JKHY | 59.6/100Mixed-positive evidence81% evidence | TURNING | 21.6/35 Revenue 8.4% · PAT 21.2% · OPM change 0.7 pp 83% evidence | 16.1/25 ROCE 6% · OPM 24.4% 76% evidence | 11.7/20 P/E 22.1× · PEG 1.01 65% evidence | 10.2/20 RS sector -9.5% · RS bench -11.8% · 1Y -3.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 21.6 + 16.1 + 11.7 + 10.2 = 59.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Broadridge Financial Solutions, Inc.BR | 58.8/100Mixed-positive evidence81% evidence | TURNING | 20.4/35 Revenue 8.2% · PAT 39.6% · OPM change -0.6 pp 83% evidence | 15.4/25 ROCE 5.2% · OPM 18.4% 76% evidence | 14.8/20 P/E 17.4× · PEG 0.43 65% evidence | 8.2/20 RS sector -20.2% · RS bench -22.8% · 1Y -36.7%1 of 12 weeks ahead 100% evidence |
| Exact sum: 20.4 + 15.4 + 14.8 + 8.2 = 58.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Gartner, Inc.IT | 57.8/100Mixed-positive evidence81% evidence | TURNING | 16.2/35 Revenue 2.3% · PAT -41% · OPM change 2.8 pp 83% evidence | 16.9/25 ROCE 7.5% · OPM 20.9% 76% evidence | 14.3/20 P/E 15.6× · PEG 0.45 65% evidence | 10.4/20 RS sector -12.3% · RS bench -15.3% · 1Y -18.9%1 of 12 weeks ahead 100% evidence |
| Exact sum: 16.2 + 16.9 + 14.3 + 10.4 = 57.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Penguin Solutions, Inc.PENG | 57.7/100Mixed-positive evidence67% evidence | LEADER | 24.6/35 Revenue 12% · PAT — · OPM change 7.6 pp 71% evidence | 10.2/25 ROCE 4.2% · OPM 10.6% 76% evidence | 8.6/20 P/E 39.6× · PEG — 15% evidence | 14.3/20 RS sector 67% · RS bench 67.3% · 1Y 148.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 24.6 + 10.2 + 8.6 + 14.3 = 57.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Innodata Inc.INOD | 56.2/100Mixed-positive evidence81% evidence | FADING | 24.0/35 Revenue 40.1% · PAT 11.4% · OPM change 4.6 pp 83% evidence | 16.4/25 ROCE 14.9% · OPM 18.8% 76% evidence | 3.9/20 P/E 34.8× · PEG 5.17 65% evidence | 11.9/20 RS sector 5.5% · RS bench 3.2% · 1Y 61.3%11 of 12 weeks ahead 100% evidence |
| Exact sum: 24 + 16.4 + 3.9 + 11.9 = 56.2 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 7ExlService Holdings, Inc.EXLS | 55.3/100Thin evidence · provisional58% evidence | TURNING | 19.2/35 Revenue — · PAT — · OPM change 0.4 pp 45% evidence | 15.9/25 ROCE 7% · OPM 16.1% 76% evidence | 9.9/20 P/E 16.3× · PEG — 15% evidence | 10.3/20 RS sector -11.1% · RS bench -13.9% · 1Y -18.5%1 of 12 weeks ahead 100% evidence |
| Exact sum: 19.2 + 15.9 + 9.9 + 10.3 = 55.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8Ingram Micro Holding CorporationINGM | 53.6/100Thin evidence · provisional58% evidence | TURNING | 18.9/35 Revenue — · PAT — · OPM change 0 pp 45% evidence | 10.4/25 ROCE 3.1% · OPM 1.6% 76% evidence | 10.3/20 P/E 15× · PEG — 15% evidence | 14.0/20 RS sector 12.6% · RS bench 10.9% · 1Y 55.8%6 of 12 weeks ahead 100% evidence |
| Exact sum: 18.9 + 10.4 + 10.3 + 14 = 53.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9CGI Inc.GIB | 51.2/100Thin evidence · provisional58% evidence | TURNING | 17.9/35 Revenue — · PAT — · OPM change 0.4 pp 45% evidence | 13.2/25 ROCE 4.3% · OPM 14.9% 76% evidence | 11.0/20 P/E 11.4× · PEG — 15% evidence | 9.1/20 RS sector -14.7% · RS bench -17.2% · 1Y -22.4%1 of 12 weeks ahead 100% evidence |
| Exact sum: 17.9 + 13.2 + 11 + 9.1 = 51.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 10Genpact LimitedG | 50.8/100Mixed-positive evidence81% evidence | TURNING | 15.1/35 Revenue 6.4% · PAT 8% · OPM change 0.2 pp 83% evidence | 14.2/25 ROCE 4.8% · OPM 15.3% 76% evidence | 13.1/20 P/E 11.4× · PEG 1.01 65% evidence | 8.4/20 RS sector -15.7% · RS bench -18.2% · 1Y -17.8%1 of 12 weeks ahead 100% evidence |
| Exact sum: 15.1 + 14.2 + 13.1 + 8.4 = 50.8 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 11ChronoScale Holdings CorporationCHRN | 50.0/100Mixed-positive evidence64% evidence | LEADER | 20.0/35 Revenue -164.9% · PAT — · OPM change 55.9 pp 62% evidence | 3.7/25 ROCE -112.9% · OPM -58.5% 76% evidence | 11.5/20 P/E 1× · PEG — 15% evidence | 14.8/20 RS sector 110.7% · RS bench 112.4% · 1Y 717.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 20 + 3.7 + 11.5 + 14.8 = 50 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Cognizant Technology Solutions CorporationCTSH | 48.8/100Thin evidence · provisional58% evidence | TURNING | 15.6/35 Revenue — · PAT — · OPM change -1.1 pp 45% evidence | 14.6/25 ROCE 5.1% · OPM 15.6% 76% evidence | 11.4/20 P/E 8.3× · PEG — 15% evidence | 7.2/20 RS sector -20.3% · RS bench -22.9% · 1Y -19.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 15.6 + 14.6 + 11.4 + 7.2 = 48.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13CDW CorporationCDW | 46.9/100Mixed-negative evidence81% evidence | TURNING | 13.9/35 Revenue 7.4% · PAT -0.8% · OPM change -0.4 pp 83% evidence | 11.3/25 ROCE 4.2% · OPM 6.6% 76% evidence | 6.0/20 P/E 14.7× · PEG 4.79 65% evidence | 15.7/20 RS sector 2.2% · RS bench -0.3% · 1Y -5.5%1 of 12 weeks ahead 100% evidence |
| Exact sum: 13.9 + 11.3 + 6 + 15.7 = 46.9 · Decision use: Price leads the evidence: RS versus the benchmark is -0.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 14CACI International IncCACI | 45.9/100Mixed-negative evidence81% evidence | TURNING | 18.0/35 Revenue 9.6% · PAT 12.6% · OPM change 0.6 pp 83% evidence | 10.6/25 ROCE 2.6% · OPM 9.7% 76% evidence | 9.3/20 P/E 22.4× · PEG 1.56 65% evidence | 8.0/20 RS sector -11.3% · RS bench -13.4% · 1Y 5.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18 + 10.6 + 9.3 + 8 = 45.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Leidos Holdings, Inc.LDOS | 44.5/100Mixed-negative evidence68% evidence | BASING | 13.5/35 Revenue — · PAT — · OPM change -1 pp 45% evidence | 12.1/25 ROCE 4.5% · OPM 11.5% 76% evidence | 14.5/20 P/E 14.5× · PEG 0.52 65% evidence | 4.4/20 RS sector -26.5% · RS bench -28.8% · 1Y -26%0 of 12 weeks ahead 100% evidence |
| Exact sum: 13.5 + 12.1 + 14.5 + 4.4 = 44.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 16Cipher Digital Inc.CIFR | 43.3/100Mixed-negative evidence64% evidence | FADING | 17.5/35 Revenue 38.8% · PAT — · OPM change -251.1 pp 62% evidence | 4.2/25 ROCE -3.9% · OPM -328.9% 76% evidence | 8.5/20 P/E 83× · PEG — 15% evidence | 13.1/20 RS sector 10% · RS bench 8.2% · 1Y 329.1%10 of 12 weeks ahead 100% evidence |
| Exact sum: 17.5 + 4.2 + 8.5 + 13.1 = 43.3 · Decision use: Price leads the evidence: RS versus the benchmark is 8.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 17EPAM Systems, Inc.EPAM | 41.9/100Mixed-negative evidence81% evidence | TURNING | 18.6/35 Revenue 14.2% · PAT -5.8% · OPM change 0.7 pp 83% evidence | 10.8/25 ROCE 3% · OPM 8.3% 76% evidence | 6.4/20 P/E 19.4× · PEG 2.74 65% evidence | 6.1/20 RS sector -29.6% · RS bench -32.2% · 1Y -29.1%1 of 12 weeks ahead 100% evidence |
| Exact sum: 18.6 + 10.8 + 6.4 + 6.1 = 41.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18International Business Machines CorporationIBM | 40.3/100Thin evidence · provisional58% evidence | ASLEEP | 16.4/35 Revenue — · PAT — · OPM change 0.6 pp 45% evidence | 9.8/25 ROCE 2.6% · OPM 11.7% 76% evidence | 9.0/20 P/E 25× · PEG — 15% evidence | 5.1/20 RS sector -19.4% · RS bench -21.5% · 1Y -2.9%2 of 12 weeks ahead 100% evidence |
| Exact sum: 16.4 + 9.8 + 9 + 5.1 = 40.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19Fidelity National Information Services, Inc.FIS | 39.8/100Mixed-negative evidence71% evidence | BASING | 12.7/35 Revenue 12.3% · PAT -257.8% · OPM change -0.9 pp 83% evidence | 9.4/25 ROCE 1.4% · OPM 12.8% 76% evidence | 11.2/20 P/E 9.1× · PEG — 15% evidence | 6.5/20 RS sector -25.9% · RS bench -28.3% · 1Y -37.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.7 + 9.4 + 11.2 + 6.5 = 39.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Keel Infrastructure Corp.KEEL | 39.8/100Mixed-negative evidence64% evidence | FADING | 12.9/35 Revenue 51.6% · PAT — · OPM change -192.9 pp 62% evidence | 3.9/25 ROCE -11.6% · OPM -266% 76% evidence | 9.5/20 P/E 20.8× · PEG — 15% evidence | 13.5/20 RS sector 17.7% · RS bench 15.9% · 1Y 231.5%11 of 12 weeks ahead 100% evidence |
| Exact sum: 12.9 + 3.9 + 9.5 + 13.5 = 39.8 · Decision use: Price leads the evidence: RS versus the benchmark is 15.9%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 21Pony AI Inc.PONY | 39.8/100Mixed-negative evidence61% evidence | BASING | 24.6/35 Revenue 41.6% · PAT — · OPM change 230.6 pp 62% evidence | 4.0/25 ROCE -4.5% · OPM -170.3% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 1.2/20 RS sector -42.4% · RS bench -44.7% · 1Y -45.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 24.6 + 4 + 10 + 1.2 = 39.8 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -42.4% and the one-year return is -45.4%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 22Accenture plcACN | 39.2/100Mixed-negative evidence85% evidence | BASING | 12.2/35 Revenue 6.7% · PAT -2% · OPM change 0.2 pp 95% evidence | 15.8/25 ROCE 6.9% · OPM 17% 76% evidence | 6.3/20 P/E 14.9× · PEG 3.4 65% evidence | 4.9/20 RS sector -27.5% · RS bench -29.9% · 1Y -28.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.2 + 15.8 + 6.3 + 4.9 = 39.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23Applied Digital CorporationAPLD | 37.6/100Thin evidence · provisional55% evidence | FADING | 16.7/35 Revenue — · PAT — · OPM change -31.8 pp 45% evidence | 4.5/25 ROCE -2.5% · OPM -67.6% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 6.4/20 RS sector -4.6% · RS bench -6.4% · 1Y 120.2%8 of 12 weeks ahead 100% evidence |
| Exact sum: 16.7 + 4.5 + 10 + 6.4 = 37.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 24Kyndryl Holdings, Inc.KD | 35.2/100Mixed-negative evidence71% evidence | TURNING | 11.9/35 Revenue 0.2% · PAT -21.4% · OPM change 0.6 pp 83% evidence | 7.1/25 ROCE 2.6% · OPM 4.3% 76% evidence | 10.2/20 P/E 15.4× · PEG — 15% evidence | 6.0/20 RS sector -32.4% · RS bench -35.3% · 1Y -52.1%1 of 12 weeks ahead 100% evidence |
| Exact sum: 11.9 + 7.1 + 10.2 + 6 = 35.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25Parsons CorporationPSN | 34.8/100Thin evidence · provisional58% evidence | BASING | 13.9/35 Revenue — · PAT — · OPM change -0.6 pp 45% evidence | 9.0/25 ROCE 0.1% · OPM 6.4% 76% evidence | 8.8/20 P/E 36.1× · PEG — 15% evidence | 3.1/20 RS sector -32.2% · RS bench -34.2% · 1Y -37.4%1 of 12 weeks ahead 100% evidence |
| Exact sum: 13.9 + 9 + 8.8 + 3.1 = 34.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 26Wise Group plcthis pageWSE | 43.6/100Thin evidence · provisional49% evidence | ASLEEP | 16.2/35 Revenue — · PAT — · OPM change -7.3 pp 19% evidence | 11.7/25 ROCE 0% · OPM 30.1% 76% evidence | 9.2/20 P/E 24.6× · PEG — 15% evidence | 6.5/20 RS sector -10.7% · RS bench -12.5% · 1Y -10.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.2 + 11.7 + 9.2 + 6.5 = 43.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 27NIQ Global Intelligence plcNIQ | 37.5/100Thin evidence · provisional47% evidence | TURNING | 16.1/35 Revenue — · PAT — · OPM change -2.6 pp 39% evidence | 4.9/25 ROCE -0.4% · OPM -1% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 6.5/20 RS sector -17.6% · RS bench -20.3% · 1Y -34.8%0 of 12 weeks ahead 70% evidence |
| Exact sum: 16.1 + 4.9 + 10 + 6.5 = 37.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Wise Group plc's stock price today?
Wise Group plc trades at $12.4, −9.9% over the past year. The company is valued at $12.0 B. The stock sits at 31% of its 52-week range of $11–$16, +0.0% versus its 200-day average. On the tape, the price is topping out, 1 weeks in. — as of 5 August 2026.
What were Wise Group plc's latest quarterly results?
Wise Group plc reported revenue of $0.6 B and net profit of $0.1 B for the Sep 25 quarter. Revenue rose 9.3% and profit fell 13.3% year on year. Earnings per share were $0.12. The operating margin was 30.5%, 6.5 pp lower than a year earlier. — as of 5 August 2026.
What is Wise Group plc's revenue?
Wise Group plc reported revenue of $0.6 B in the Sep 25 quarter, +9.3% year on year. For the full FY26 fiscal year, revenue was $2.5 B (+19.0%). Over the last 4 years revenue compounded at 36.0% a year. — as of 5 August 2026.
What is Wise Group plc's profit?
Wise Group plc earned $0.1 B of net profit in the Sep 25 quarter, −13.3% year on year. Full-year FY26 profit was $0.5 B. The operating margin ran 30.5% in the latest quarter. — as of 5 August 2026.
What is Wise Group plc's market cap?
Wise Group plc's market capitalisation is $12.0 B at a stock price of $12.4. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
Does Wise Group plc pay a dividend?
No — Wise Group plc has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.
Is Wise Group plc growing?
Yes — Wise Group plc is growing: latest-quarter revenue +9.3% year on year, profit −13.3%, and the margin −6.5 pp at 30.5%. The 4-year compound rates are 36.0% (revenue) and 88.0% (profit). The earnings engine currently reads: improving — as of 5 August 2026.
How is Wise Group plc performing?
Wise Group plc is topping out, 1 weeks in. Its latest quarter's revenue rose 9.3% and profit fell 13.3% year on year. Against the S&P 500 it has been behind on a trailing-13-week view for 10 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
What stage is Wise Group plc in?
Mixed — growth is normalizing off a hyper-growth base: revenue growth has eased from +73.1% at its peak to +48.7% but is still expanding, ROCE holding at 45.0%. The read comes from the last 12 quarters of growth (revenue growth +48.7% latest, profit growth +100.0% latest, eps growth +100.0% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.
Is Wise Group plc in an uptrend?
It is stalling — the price is topping out (week 1 of stage 3), trading +0.0% versus its 200-day average and at 31% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.
Is Wise Group plc beating the market?
Not lately — on a trailing-13-week view Wise Group plc is currently behind the S&P 500 (10 weeks and counting; last ahead the week of 2026-05-29), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 5.1 years the stock moved −6% against the S&P 500's +77% — behind the index over the full window. — as of 5 August 2026.
Will Wise Group plc's stock price go up?
This page publishes no price forecast for Wise Group plc. What it measures instead: the stock price is $12.4, the price is topping out 1 weeks in. Direction is not something this site claims to know. — as of 5 August 2026.
Is the market betting against Wise Group plc?
No — short interest is 0.5% of Wise Group plc's tradable float, about 2.6 days to cover at typical volumes. That is a low reading: the crowd is not positioned against this stock. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.
Does Wise Group plc have too much debt?
No — Wise Group plc's debt-to-equity is 0.25. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. The returns on this page are earned, not borrowed — as of 5 August 2026.
What is Wise Group plc's capex?
Wise Group plc spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was $0.0 B. — as of 5 August 2026.
What is Wise Group plc's cash flow?
Wise Group plc generated $5.7 B of operating cash flow in FY26 and $7.5 B of free cash flow after $0.0 B of capital spending. Reported profit that year was $0.5 B, so operating cash ran ahead of profit. — as of 5 August 2026.
Is Wise Group plc's profit real cash?
Yes — over the last 3 fiscal years, 867% of Wise Group plc's reported profit arrived as operating cash. In FY26, operating cash was $5.7 B against reported profit of $0.5 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.
How financially safe is Wise Group plc?
On the balance sheet, the Z-score reads 0.60 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is inside the danger band — a real balance-sheet risk. — as of 5 August 2026.
Where is Wise Group plc in its business cycle?
Wise Group plc's FY26 operating margin was 23.6%, against a 5-year band of 8.2%–36.5%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 30.5%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the Wise Group plc story?
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is Wise Group plc a stock worth studying right now?
This is not investment advice. The machine read: Wise Group plc's earnings have outrun its stock. EPS grew −8.0% in a year against a −9.9% price move. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.